Imaging Tumor Xenografts Using Radiolabeled Antibodies
Authors:
- 1 January 2010
- book chapter
- Published by Springer Nature
- p. 491-506
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Antibodies and Antimatter: The Resurgence of Immuno-PETJournal of Nuclear Medicine, 2008
- Antibodies for Molecular Imaging of CancerThe Cancer Journal, 2008
- Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragmentNature Protocols, 2006
- Performance of Immuno–Positron Emission Tomography with Zirconium-89-Labeled Chimeric Monoclonal Antibody U36 in the Detection of Lymph Node Metastases in Head and Neck Cancer PatientsClinical Cancer Research, 2006
- Identification of a Novel Prostate Tumor Target, Mindin/RG-1, for Antibody-Based Radiotherapy of Prostate CancerCancer Research, 2005
- Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal CancerClinical Cancer Research, 2004
- Tumor Targeting of Radiometal Labeled Anti-CEA Recombinant T84.66 Diabody and T84.66 Minibody: Comparison to Radioiodinated FragmentsBioconjugate Chemistry, 2001
- A Facile, Water-Soluble Method for Modification of Proteins with DOTA. Use of Elevated Temperature and Optimized pH To Achieve High Specific Activity and High Chelate Stability in Radiolabeled ImmunoconjugatesBioconjugate Chemistry, 1994
- Antibody fragments labeled with fluorine-18 and gallium-68: In vivo comparison with indium-111 and iodine-125-labeled fragmentsInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
- Fluorine-18 labeling of monoclonal antibodies and fragments with preservation of immunoreactivityBioconjugate Chemistry, 1991